Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study of Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Conditions
Interventions
Belimumab
Rituximab
+3 more
Locations
1
United States
Hospital for Special Surgery
New York, New York, United States
Start Date
July 29, 2019
Primary Completion Date
June 30, 2026
Completion Date
June 30, 2026
Last Updated
March 27, 2026
NCT06329401
NCT06947460
NCT07413341
NCT04402086
NCT07295847
NCT07361094
Lead Sponsor
Hospital for Special Surgery, New York
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions